Ergoteles LLC Abb Vie Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.44 Million - $2.8 Million	18,178 Added 705.94%	20,753 $2.79 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $416,988 - $530,128	-3,030 Reduced 54.06%	2,575 $394,000
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $111,787 - $138,696	847 Added 17.8%	5,605 $909,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $511,151 - $646,754	4,758 New	4,758 $644,000
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $5.54 Million - $6.1 Million	-54,187 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $4.36 Million - $5.89 Million	54,187 New	54,187 $5.81 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.